How AI, automation, and healthcare data interoperability can support patient care throughout the healthcare system, particularly in the pharmacy and pharmaceutical distribution sectors Policies and programs aimed at red tape reduction to reduce regulatory burdens and timelines in the pharmaceutical distribution and associated sectors Offer recommendations on the Patented Medicines Pricing Review Board excessive pricing policy guidelines and implementation approaches to support drug supply stability and system sustainability Discuss policy measures to protect Canada's drug supply, distribution, and pharmacy systems against the impact of US tariffs Medical cannabis policy impacts on pharmacy and the wholesale industry Health Canada, with respect to the role of wholesalers in the management of drug shortages Health Canada, with respect to the regulation and funding of wholesale distribution of pharmaceuticals and regulation of pharmacy activities Health Canada, with respect to pandemic planning, particularly federal/provincial/territorial storage and distribution of pharmaceuticals Development of screening programs in First Nations communities Approaches towards National Pharmacare policy Approaches to mitigating the impact of COVID-19 on the pharmaceutical distribution, pharmacy, primary care, and other healthcare sectors